8-K/AShareholder Matters

ABBOTT LABORATORIES 8-K/A Report, Shareholder Vote Results (Sep 1, 2023)

Filed September 1, 2023For Securities:ABT

Summary

This 8-K filing is an amendment to a previous report filed on May 2, 2023, concerning Abbott Laboratories' (ABT) Annual Meeting of Shareholders held on April 28, 2023. The primary purpose of this amendment is to correct a typographical error in the reported number of shares cast against Michael F. Roman, a key executive. The amendment clarifies the voting results for Mr. Roman, providing updated figures for votes cast for, against, abstentions, and broker non-votes. For investors, this filing is largely administrative and confirms the original outcome of the shareholder vote regarding Mr. Roman's re-election. While the correction itself is minor and does not alter the overall outcome of the shareholder vote, it demonstrates Abbott's commitment to accurate reporting. The overwhelming majority of votes were cast in favor of Mr. Roman, indicating continued shareholder confidence in leadership.

Key Highlights

  • 1Amendment to a prior 8-K filing regarding the 2023 Annual Meeting of Shareholders.
  • 2Corrects a typographical error in the number of shares voted against Michael F. Roman.
  • 3Provides updated and accurate voting tallies for Michael F. Roman: 1,315,610,421 votes For, 25,575,883 votes Against, 2,597,363 Abstain, and 179,678,846 Broker Non-Votes.
  • 4The correction does not change the overall outcome of the vote concerning Michael F. Roman.
  • 5Demonstrates commitment to accurate corporate disclosures.
  • 6Confirms continued shareholder support for the company's leadership.

Frequently Asked Questions

This filing is an amendment to a previous 8-K report to correct a minor typographical error in the number of shares voted against Michael F. Roman at Abbott Laboratories' Annual Meeting of Shareholders.

No, the amendment clarifies and corrects the vote count but does not alter the overall outcome. Michael F. Roman received a substantial majority of the votes in favor, indicating continued shareholder support.

Broker non-votes occur when a broker holding shares in 'street name' does not have discretionary voting authority for a particular proposal and has not received voting instructions from the beneficial owner. This is common in shareholder meetings.

No, this filing is specifically an amendment to correct a voting disclosure and does not contain any new financial results, operational updates, or material business developments.